I am/have/had
I am looking for
Advanced Filters
Found 21 clinical trials
Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies
EXALT-2 is a prospective, randomized, three arm study for treatment decision guided either by either comprehensive genomic profiling, next generation drug screening or physician's choice
cancer
melanoma of the skin
basal cell carcinoma of the skin
- 0 views
- 19 Feb, 2024